|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/14/24 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/14/23 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.67% | +2.53% | -9.83% | -19.85% | 25TCr | ||
| +2.82% | +1.91% | -3.32% | -41.99% | 5.19TCr | ||
| -0.37% | +1.28% | -40.48% | -50.08% | 4.19TCr | ||
| -1.81% | -4.03% | -42.74% | -51.37% | 2.02TCr | ||
| +3.05% | +1.50% | -25.11% | -59.57% | 1.85TCr | ||
| -1.71% | -3.27% | -49.33% | -65.48% | 1.53TCr | ||
| +5.54% | +3.95% | +5.77% | -46.17% | 1.3TCr | ||
| -0.91% | -7.03% | -5.53% | +23.50% | 975.39Cr | ||
| +2.44% | +3.42% | +13.35% | -38.80% | 881.32Cr | ||
| Average | +1.11% | -2.10% | -17.47% | -38.87% | 4.72TCr | |
| Weighted average by Cap. | +0.92% | -1.17% | -14.65% | -30.61% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















